If testing reveals you carry FTO variants linked to increased appetite or MC4R variants affecting satiety signaling, you'll know in advance that your rebound risk is elevatedand you can plan accordingly with behavioral, dietary, and possibly pharmacological strategies
It belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists , which were initially developed to treat type 2 diabetes
Of course, the FDA only considers the United States
Standard protocols suggest 0.25-0.5 mg daily via subcutaneous injection for 4-8 weeks, though optimal dosing for rib injuries has not been established in human clinical trials
Theyre primarily prescribed for diabetes and weight loss in people with obesity
367 The administration of liraglutide also impeded osteoclastic bone formation, thereby inhibiting bone resorption and exerting protective effects on bone health in T1D mice